Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Noxopharm Ltd. ( (AU:NOX) ) is now available.
Noxopharm Limited has issued 15 million fully paid ordinary shares at an issue price of zero dollars per share under a financing facility announced on 27 February 2026, expanding its capital base without providing a disclosure document to investors. The company stated it remains compliant with its financial reporting and continuous disclosure obligations under the Corporations Act and confirmed there is no excluded information that would affect the market, underscoring regulatory transparency around the new share issuance.
The notice clarifies that the share issue was conducted in accordance with section 708A(5)(e) of the Corporations Act, which allows certain placements without a prospectus, potentially streamlining Noxopharm’s access to funding to support its development programs. While the issue price of zero implies the shares were issued as part of an existing financing arrangement rather than a conventional capital raising, it nonetheless alters the company’s share structure and may have implications for existing shareholders in terms of dilution and future funding flexibility.
The most recent analyst rating on (AU:NOX) stock is a Hold with a A$0.07 price target. To see the full list of analyst forecasts on Noxopharm Ltd. stock, see the AU:NOX Stock Forecast page.
More about Noxopharm Ltd.
Noxopharm Limited (ASX:NOX) is a clinical-stage Australian biotechnology company focused on discovering and developing novel treatments for cancer and inflammation, including technologies aimed at improving the safety profile of mRNA medicines. Its pipeline is built on two proprietary platforms, Sofra for inflammation, autoimmunity, mRNA drug enhancement and oncology, and Chroma for oncology, supported by in-house capabilities and partnerships with leading researchers.
Average Trading Volume: 172,577
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$20.46M
Find detailed analytics on NOX stock on TipRanks’ Stock Analysis page.